ATE476408T1 - 4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga - Google Patents
4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analogaInfo
- Publication number
- ATE476408T1 ATE476408T1 AT04784146T AT04784146T ATE476408T1 AT E476408 T1 ATE476408 T1 AT E476408T1 AT 04784146 T AT04784146 T AT 04784146T AT 04784146 T AT04784146 T AT 04784146T AT E476408 T1 ATE476408 T1 AT E476408T1
- Authority
- AT
- Austria
- Prior art keywords
- phenoxyalkyl
- thio
- analogs
- phenoxyacetic acids
- phenoxyacetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50408903P | 2003-09-19 | 2003-09-19 | |
PCT/US2004/030188 WO2005030694A1 (en) | 2003-09-19 | 2004-09-16 | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE476408T1 true ATE476408T1 (de) | 2010-08-15 |
Family
ID=34392924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04784146T ATE476408T1 (de) | 2003-09-19 | 2004-09-16 | 4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga |
Country Status (31)
Country | Link |
---|---|
US (4) | US7598292B2 (de) |
EP (2) | EP1670744B9 (de) |
JP (1) | JP5016922B2 (de) |
KR (1) | KR101094742B1 (de) |
CN (1) | CN1882524B (de) |
AR (1) | AR045774A1 (de) |
AT (1) | ATE476408T1 (de) |
AU (1) | AU2004276231B2 (de) |
BR (1) | BRPI0414534B8 (de) |
CA (1) | CA2539403C (de) |
CO (1) | CO5680473A2 (de) |
CR (1) | CR8303A (de) |
CY (2) | CY1110847T1 (de) |
DE (1) | DE602004028500D1 (de) |
DK (2) | DK2243766T3 (de) |
EA (1) | EA009119B1 (de) |
EC (1) | ECSP066435A (de) |
ES (2) | ES2349143T3 (de) |
HK (1) | HK1093060A1 (de) |
HU (1) | HUE028213T2 (de) |
IL (1) | IL174399A (de) |
NO (1) | NO337041B1 (de) |
NZ (1) | NZ545971A (de) |
PL (2) | PL2243766T3 (de) |
PT (2) | PT2243766E (de) |
SG (1) | SG149041A1 (de) |
SI (2) | SI2243766T1 (de) |
TW (1) | TWI330630B (de) |
UA (1) | UA87468C2 (de) |
WO (1) | WO2005030694A1 (de) |
ZA (1) | ZA200603084B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7301050B2 (en) | 2003-09-19 | 2007-11-27 | Janssen Pharmaceutical N.V. | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
MY147518A (en) * | 2004-09-15 | 2012-12-31 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
MY145712A (en) * | 2004-09-15 | 2012-03-30 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
JO3006B1 (ar) * | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
UY30288A1 (es) * | 2006-04-18 | 2007-08-31 | Janssen Pharmaceutica Nv | Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol |
AU2011296737A1 (en) | 2010-08-31 | 2013-04-11 | Snu R&Db Foundation | Use of the fetal reprogramming of a PPAR delta agonist |
CN103183612A (zh) * | 2011-12-30 | 2013-07-03 | 北大方正集团有限公司 | 二丙基丙二酸二酯的制备方法 |
US9073943B2 (en) | 2012-02-10 | 2015-07-07 | Lupin Limited | Antiviral compounds with a dibenzooxaheterocycle moiety |
CN106188097B (zh) * | 2016-07-08 | 2018-01-05 | 郑州大学 | 一种3‑氯甲基氧头孢烯类抗生素母核的制备方法 |
PT3522880T (pt) * | 2016-10-05 | 2021-02-22 | Mitobridge Inc | Métodos de tratamento de lesão renal aguda |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4125732A (en) * | 1977-05-06 | 1978-11-14 | American Cyanamid Company | 2-Aryloxy-2-(phenoxyalkoxy)phenyl acetic acid and esters |
DE3169761D1 (en) | 1981-01-09 | 1985-05-09 | Fisons Plc | Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them |
JPS58177934A (ja) | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | ベンゾキノン誘導体 |
ATE22072T1 (de) | 1982-09-30 | 1986-09-15 | Merck Frosst Canada Inc | Leukotrienantagonisten, deren herstellung und diese enthaltende zusammensetzungen. |
US4820867A (en) * | 1983-04-21 | 1989-04-11 | Merck Frosst Canada, Inc. | Phenoxypropoxy halophenylacetic acids as leukotriene antagonists |
JPS61268651A (ja) * | 1985-05-23 | 1986-11-28 | Takeda Chem Ind Ltd | フエニル酢酸誘導体およびその製造法 |
US5726165A (en) * | 1994-07-29 | 1998-03-10 | Smithkline Beecham P.L.C. | Derivatives of 4-(2-aminoethyl)phenoxymethyl-phosphonic and -phosphinic acid and pharmaceutical and veterinary uses therefor |
AU712607B2 (en) * | 1996-02-02 | 1999-11-11 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
CA2315397C (en) * | 1997-12-19 | 2007-08-07 | Merck & Co., Inc. | Arylthiazolidinedione derivatives |
DE60029446T2 (de) * | 1999-06-18 | 2007-02-08 | Merck & Co., Inc. | Arylthiazolidindione und aryloxazolidindion-derivate |
GB9914977D0 (en) | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
GB0003310D0 (en) * | 2000-02-15 | 2000-04-05 | Univ Sheffield | Bone formation |
CN1537093A (zh) * | 2001-07-30 | 2004-10-13 | ŵ��Ų�ڿ˹�˾ | 新乙烯基羧酸衍生物以及它们作为抗糖尿病等药物的用途 |
AU2003224632A1 (en) | 2002-03-01 | 2003-09-16 | Smithkline Beecham Corporation | Hppars activators |
WO2005019151A1 (en) | 2003-08-20 | 2005-03-03 | Eli Lilly And Company | Ppar modulators |
US7301050B2 (en) * | 2003-09-19 | 2007-11-27 | Janssen Pharmaceutical N.V. | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
MY145712A (en) | 2004-09-15 | 2012-03-30 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
MY147518A (en) | 2004-09-15 | 2012-12-31 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
JO3006B1 (ar) * | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
-
2004
- 2004-09-16 JP JP2006526992A patent/JP5016922B2/ja not_active Expired - Lifetime
- 2004-09-16 CA CA2539403A patent/CA2539403C/en not_active Expired - Lifetime
- 2004-09-16 DE DE602004028500T patent/DE602004028500D1/de not_active Expired - Lifetime
- 2004-09-16 DK DK10008042.3T patent/DK2243766T3/en active
- 2004-09-16 SI SI200432276T patent/SI2243766T1/sl unknown
- 2004-09-16 ES ES04784146T patent/ES2349143T3/es not_active Expired - Lifetime
- 2004-09-16 KR KR1020067007361A patent/KR101094742B1/ko active IP Right Grant
- 2004-09-16 EA EA200600439A patent/EA009119B1/ru unknown
- 2004-09-16 AT AT04784146T patent/ATE476408T1/de active
- 2004-09-16 PL PL10008042T patent/PL2243766T3/pl unknown
- 2004-09-16 US US10/942,563 patent/US7598292B2/en active Active
- 2004-09-16 EP EP04784146A patent/EP1670744B9/de not_active Expired - Lifetime
- 2004-09-16 NZ NZ545971A patent/NZ545971A/en not_active IP Right Cessation
- 2004-09-16 DK DK04784146.5T patent/DK1670744T5/da active
- 2004-09-16 WO PCT/US2004/030188 patent/WO2005030694A1/en active Application Filing
- 2004-09-16 HU HUE10008042A patent/HUE028213T2/en unknown
- 2004-09-16 PL PL04784146T patent/PL1670744T3/pl unknown
- 2004-09-16 SI SI200431520T patent/SI1670744T1/sl unknown
- 2004-09-16 UA UAA200603108A patent/UA87468C2/ru unknown
- 2004-09-16 ES ES10008042.3T patent/ES2555031T3/es not_active Expired - Lifetime
- 2004-09-16 CN CN2004800337382A patent/CN1882524B/zh not_active Expired - Lifetime
- 2004-09-16 AU AU2004276231A patent/AU2004276231B2/en not_active Expired
- 2004-09-16 BR BRPI0414534A patent/BRPI0414534B8/pt active IP Right Grant
- 2004-09-16 PT PT100080423T patent/PT2243766E/pt unknown
- 2004-09-16 EP EP10008042.3A patent/EP2243766B1/de not_active Expired - Lifetime
- 2004-09-16 PT PT04784146T patent/PT1670744E/pt unknown
- 2004-09-16 SG SG200809395-7A patent/SG149041A1/en unknown
- 2004-09-17 TW TW093127865A patent/TWI330630B/zh active
- 2004-09-20 AR ARP040103377A patent/AR045774A1/es active IP Right Grant
-
2006
- 2006-03-17 EC EC2006006435A patent/ECSP066435A/es unknown
- 2006-03-19 IL IL174399A patent/IL174399A/en active IP Right Grant
- 2006-03-20 CR CR8303A patent/CR8303A/es unknown
- 2006-03-30 CO CO06031467A patent/CO5680473A2/es active IP Right Grant
- 2006-04-18 ZA ZA200603084A patent/ZA200603084B/en unknown
- 2006-04-19 NO NO20061711A patent/NO337041B1/no unknown
- 2006-12-15 HK HK06113838.3A patent/HK1093060A1/xx not_active IP Right Cessation
-
2009
- 2009-08-28 US US12/549,431 patent/US8008513B2/en not_active Expired - Lifetime
-
2010
- 2010-10-18 CY CY20101100933T patent/CY1110847T1/el unknown
-
2011
- 2011-08-11 US US13/207,809 patent/US8258177B2/en not_active Expired - Lifetime
-
2012
- 2012-08-29 US US13/597,316 patent/US8450371B2/en not_active Expired - Lifetime
-
2015
- 2015-11-06 CY CY20151100994T patent/CY1117666T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE542793T1 (de) | 4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga | |
HK1101758A1 (zh) | 苯氧基烷基 硫基 -苯氧基乙酸及類似物 | |
IL174399A0 (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
ATE444753T1 (de) | Gepufferte flüssige nikotinzusammensetzung zur pulmonalen verabreichung | |
DE60301088D1 (de) | Chirurgische Kassette | |
IS7571A (is) | Ný lífeðlisfræðilega virk efni | |
FR2846545B1 (fr) | Implant d'osteosynthese intramedullaire | |
HK1104523A1 (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs 4-(())- | |
IS7528A (is) | Nýir etónógestrel esterar | |
DK1572229T3 (da) | Stabilt terapeutisk fibrinogen | |
DK1666473T3 (da) | Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens | |
DE60319319D1 (de) | Augenheilkundegerät | |
DE60312270D1 (de) | Bowlingbahn | |
FI20020126A0 (fi) | Koostumuksia pulmonaaliseen antoon | |
FR2837672B1 (fr) | Delices inca | |
SE0201442D0 (sv) | Patientlyft | |
SE0201606D0 (sv) | Patientlyft | |
PT9741T (pt) | Protector para a parte inferior de uma escora | |
ITBO20020010V0 (it) | Joystick | |
UA6774S (uk) | Натільна пов`язка для суглобів | |
FI20021270A0 (fi) | Rahapelin tuloksen seuraaminen | |
PT102715A (pt) | Controlador ddc universal programavel | |
DOP2002000508A (es) | Composición farmaceutica | |
ITMI20020112A1 (it) | Contenitore per pizza da asporto | |
ES1051860Y (es) | Plataforma elevadora |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1670744 Country of ref document: EP |